Kiniksa Pharmaceuticals International, plc Amortization of Intangible Assets in USD from Q2 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Kiniksa Pharmaceuticals International, plc quarterly Amortization of Intangible Assets history and growth rate from Q2 2024 to Q3 2025.
  • Kiniksa Pharmaceuticals International, plc Amortization of Intangible Assets for the quarter ending September 30, 2025 was $250K, unchanged year-over-year.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)

Kiniksa Pharmaceuticals International, plc Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $250K $0 0% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 $250K $0 0% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-29
Q3 2024 $250K Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 $250K Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.